Sanofi X Paris 2024

At Sanofi, we’re proud to be premium partner of Paris 2024.

Our Latest Stories

Your Health

August 22, 2024

Ending the Diagnostic Odyssey Is the Beginning of Better Care in ASMD

Shuang Yang, Scientist, China

Second quarter 2024 results

Second quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

Thursday July 25, 2024
14:30 - 16:00 CET (8:30am – 10am EST)

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

Igniting the Potential in Everyone

We’re proud to be premium partner of Paris 2024.

Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline

5

Therapeutic areas

78

Compounds in clinical development

29

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases

August 26, 2024
Media Update: ERS: New data highlight Sanofi’s scientific innovation and leadership in immune-mediated respiratory diseases
August 8, 2024
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
July 25, 2024
Press Release: Online availability of Sanofi’s half-year financial report for 2024
July 25, 2024
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded